UTHR vs. NVT
UTHR (United Therapeutics Corporation) and NVT (nVent Electric plc) are both stocks. UTHR operates in Biotechnology (Healthcare), while NVT operates in Electrical Equipment & Parts (Industrials). Over the past 5 years, UTHR returned 24.97%/yr vs 41.15%/yr for NVT. At a 0.25 correlation, their price movements are largely independent.
Performance
UTHR vs. NVT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UTHR achieves a 12.05% return, which is significantly lower than NVT's 63.18% return.
UTHR
- 1D
- 0.10%
- 1M
- -5.79%
- YTD
- 12.05%
- 6M
- 10.52%
- 1Y
- 90.80%
- 3Y*
- 33.49%
- 5Y*
- 24.97%
- 10Y*
- 17.67%
NVT
- 1D
- 0.80%
- 1M
- -4.09%
- YTD
- 63.18%
- 6M
- 63.60%
- 1Y
- 139.62%
- 3Y*
- 52.46%
- 5Y*
- 41.15%
- 10Y*
- —
UTHR vs. NVT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
UTHR United Therapeutics Corporation | 12.05% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -1.10% |
NVT nVent Electric plc | 63.18% | 51.27% | 16.63% | 55.98% | 3.32% | 67.15% | -5.68% | 17.24% | 7.52% |
Correlation
The correlation between UTHR and NVT is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since May 1, 2018 | 0.25 |
Fundamentals
UTHR:
$25.77B
NVT:
$27.20B
UTHR:
$27.00
NVT:
$3.00
UTHR:
20.22
NVT:
55.32
UTHR:
0.66
NVT:
1.33
UTHR:
8.21
NVT:
6.29
UTHR:
4.37
NVT:
7.16
UTHR:
$3.17B
NVT:
$4.33B
UTHR:
$2.74B
NVT:
$1.60B
UTHR:
$1.75B
NVT:
$857.60M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UTHR vs. NVT — Risk / Return Rank
UTHR
NVT
UTHR vs. NVT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and nVent Electric plc (NVT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| UTHR | NVT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.49 | ||
| Sortino ratioReturn per unit of downside risk | +0.35 | ||
| Omega ratioGain probability vs. loss probability | 1.49 | 1.51 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 8.58 | 8.30 | +0.28 |
| Martin ratioReturn relative to average drawdown | 20.13 | 28.25 | -8.12 |
Loading charts...
Drawdowns
UTHR vs. NVT - Drawdown Comparison
The maximum UTHR drawdown since its inception was -93.18%, which is greater than NVT's maximum drawdown of -56.18%. Use the drawdown chart below to compare losses from any high point for UTHR and NVT.
Loading charts...
Drawdown Indicators
| UTHR | NVT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -93.18% | -56.18% | -37.00% |
Max Drawdown (1Y)Largest decline over 1 year | -10.64% | -16.93% | +6.29% |
Max Drawdown (3Y)Largest decline over 3 years | -33.00% | -46.67% | +13.67% |
Max Drawdown (5Y)Largest decline over 5 years | -33.00% | -46.67% | +13.67% |
Max Drawdown (10Y)Largest decline over 10 years | -55.56% | — | — |
Current DrawdownCurrent decline from peak | -8.51% | -5.98% | -2.53% |
Average DrawdownAverage peak-to-trough decline | -35.31% | -11.82% | -23.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.53% | 4.96% | -0.43% |
Volatility
UTHR vs. NVT - Volatility Comparison
The current volatility for United Therapeutics Corporation (UTHR) is 5.01%, while nVent Electric plc (NVT) has a volatility of 12.76%. This indicates that UTHR experiences smaller price fluctuations and is considered to be less risky than NVT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UTHR | NVT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.01% | 12.76% | -7.75% |
Volatility (6M)Calculated over the trailing 6-month period | 25.94% | 32.57% | -6.63% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.55% | 41.19% | +6.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 35.08% | 36.06% | -0.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.06% | 38.49% | -3.43% |
Dividends
UTHR vs. NVT - Dividend Comparison
UTHR has not paid dividends to shareholders, while NVT's dividend yield for the trailing twelve months is around 0.49%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
NVT nVent Electric plc | 0.49% | 0.78% | 1.12% | 1.18% | 1.82% | 1.84% | 3.01% | 2.74% | 1.56% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
UTHR vs. NVT - Financials Comparison
This section allows you to compare key financial metrics between United Therapeutics Corporation and nVent Electric plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
UTHR vs. NVT - Profitability Comparison
UTHR - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a gross profit of 648.10M and revenue of 781.50M. Therefore, the gross margin over that period was 82.9%.
NVT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported a gross profit of 445.60M and revenue of 1.24B. Therefore, the gross margin over that period was 35.9%.
UTHR - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported an operating income of 325.80M and revenue of 781.50M, resulting in an operating margin of 41.7%.
NVT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported an operating income of 195.70M and revenue of 1.24B, resulting in an operating margin of 15.8%.
UTHR - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, United Therapeutics Corporation reported a net income of 274.90M and revenue of 781.50M, resulting in a net margin of 35.2%.
NVT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, nVent Electric plc reported a net income of 142.40M and revenue of 1.24B, resulting in a net margin of 11.5%.
Frequently Asked Questions
UTHR and NVT have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVT has higher volatility (12.76%) compared to UTHR (5.01%). In terms of maximum drawdown, UTHR dropped -93.18% vs NVT's -56.18%.
NVT currently has the higher Sharpe Ratio (3.41 vs 1.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UTHR and NVT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer